Funding for this research was provided by:
Fonds de Recherche du Québec - Santé
Personalized Medicine Partnership for Cancer
Text and Data Mining valid from 2020-02-07
Received: 13 August 2019
Accepted: 29 January 2020
First Online: 7 February 2020
Ethics approval and consent to participate
: The study was approved by the institutional review board at each participating hospital and complied with Good Clinical Practices, the principles of the Declaration of Helsinki and all applicable regulatory requirements. All patients provided written informed consent prior to any study specific procedures.
: Not applicable.
: The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. Mathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay No relationship to disclose. Nicole Bouchard Consulting/Advisory role for Pfizer, Astra Zeneca, Merck, BMS. Honoraria: Astra Zeneca, Merck, BMS. Research funding: Pfizer, BMS. Razvan Diaconescu, Vincent Pelsser, Valerie Higenell, Luisa Izzi, Karen Gambaro, Cyrla Hoffert, Gwenaël Pottiez, Alan Spatz, Suzan McNamara, Victor Cohen: No relationship to disclose. Normand Blais: Consulting/Advisory role for Pfizer, Astra Zeneca, Merck, BMS, Sanofi, Roche, Boehringer Ingelheim, Bayer. Research funding: Merck. Christian Couture: Consulting/Advisory role for Pfizer, BMS, Roche, Astra Zeneca, Merck, Abbvie. Research funding: Pfizer, Merck. Hangjun Wang: Consulting/Advisory role for Merck, Pfizer, Astra Zeneca. Laura McIntosh, Valérie Hindie, Stéphane Parent, Laetitia Cortes, Pascal Croteau, Yannick-André Breton: Caprion Biosciences Inc. employee at the time the work was performed. Gerald Batist: Works with multiple pharma, including Pfizer, Roche, BMS, Novartis and others on clinical trials unrelated to this present work. Jason Agulnik: Consulting/Advisory role for Takeda, Roche, Boehringer Ingelheim, Novartis. Honoraria: Astra Zeneca, BMS, Merck, Pfizer.